2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine → HCID 69291047, 화합물
반응식
Br[C:2]1[CH:3]=[N:4][C:5]2[CH2:12][N:11]([C:13](=[O:15])[CH3:14])[C:10]3[CH:16]=[CH:17][CH:18]=[CH:19][C:9]=3[CH:8]=[CH:7][C:6]=2[CH:20]=1.[CH3:21][O:22][C:23]1[CH:28]=[CH:27][C:26](B2OC(C)(C)C(C)(C)O2)=[CH:25][N:24]=1.C(N1C2C=CC=CC=2C=CC2N=C(C3C=NC(OC)=CC=3)C(F)=CC=2C1)(=O)C>>[C:13]([N:11]1[C:10]2[CH:16]=[CH:17][CH:18]=[CH:19][C:9]=2[CH:8]=[CH:7][C:6]2[CH:20]=[C:2]([C:26]3[CH:25]=[N:24][C:23]([O:22][CH3:21])=[CH:28][CH:27]=3)[CH:3]=[N:4][C:5]=2[CH2:12]1)(=[O:15])[CH3:14]참가 물질
4
반응물 3
생성물 1
실험 절차
Compound 52D (20.9 mg, 91%) was prepared from 52C (20 mg, 0.061 mmol) and 2A (14.3 mg, 0.061 mmol) by a route analogous to that used for the preparation of 2B. HPLC Rt=2.419 min; LCMS Found: (M+H)+=358.